Sutro Biopharma, Inc. (FRA:S090)
Germany · Delayed Price · Currency is EUR 8.56
+0.57 (7.13%)
At close: Jan 7, 2026
Sutro Biopharma Market Cap
Sutro Biopharma has a market cap or net worth of €89.57 million as of January 9, 2026. Its market cap has decreased by -39.60% in one year.
Market Cap
89.57M
Enterprise Value
-39.32M
Revenue
90.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
€8.56
Market Cap Chart
Since September 27, 2018, Sutro Biopharma's market cap has decreased from 297.24M to 89.57M, a decrease of -69.86%. That is a compound annual growth rate of -15.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 89.57M | 6.70% |
| Dec 31, 2025 | 83.95M | -42.71% |
| Dec 31, 2024 | 146.55M | -38.05% |
| Dec 29, 2023 | 236.57M | -45.56% |
| Dec 30, 2022 | 434.54M | -28.22% |
| Dec 31, 2021 | 605.40M | -25.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |